Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autoimmune hemophilia at rescue.

Literature DB >> 19336750

Autoimmune hemophilia at rescue.

Pier Mannuccio Mannucci¹, Flora Peyvandi.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19336750 PMCID： PMC2663608 DOI： 10.3324/haematol.2009.005777

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

12 in total

1. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors: Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal: Blood Date: 2006-10-17 Impact factor: 22.113

2. A fatal thrombotic disorder associated with an acquired inhibitor of protein C.

Authors: C A Mitchell; J A Rowell; L Hau; J P Young; H H Salem
Journal: N Engl J Med Date: 1987-12-24 Impact factor: 91.245

3. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease.

Authors: A D'Angelo; P Della Valle; L Crippa; E Pattarini; L M Grimaldi; S Viganò D'Angelo
Journal: N Engl J Med Date: 1993-06-17 Impact factor: 91.245

4. A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.

Authors: E Santagostino; M E Mancuso; A Rocino; G Mancuso; F Scaraggi; P M Mannucci
Journal: J Thromb Haemost Date: 2006-02 Impact factor: 5.824

5. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.

Authors: Khan Kavakli; Mike Makris; Bulent Zulfikar; Elizabeth Erhardtsen; Zvi S Abrams; Gili Kenet
Journal: Thromb Haemost Date: 2006-04 Impact factor: 5.249

6. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors: H M Tsai; E C Lian
Journal: N Engl J Med Date: 1998-11-26 Impact factor: 91.245

7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors: M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal: N Engl J Med Date: 1998-11-26 Impact factor: 91.245

8. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.

Authors: D Green; A W Rademaker; E Briët
Journal: Thromb Haemost Date: 1993-11-15 Impact factor: 5.249

Autoimmune hemophilia at rescue.

1. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

2. A fatal thrombotic disorder associated with an acquired inhibitor of protein C.

3. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease.

4. A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.

5. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.

6. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

8. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.

9. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

10. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

1. Cautions and caveats to the treatment of acquired hemophilia A.

2. Acquired haemophilia A: a case report.

3. Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.